Clinical OMICs empowers healthcare professionals to harness the application of molecular-based
technologies to transform patient care through a combination of news, contributed articles, and expert analysis.
Findings point to drivers of early cancer development, targets for cancer prevention therapies.
Gene mutation was associated with reduced levels of non-HDL cholesterol and a reduced risk of coronary artery disease.
We will explore how liquid biopsies are shaping the diagnostic landscape and how it will impact physician decision making and patient care.
2015 was a phenomenal year full of new developments for the structures and mechanisms of CRISPR systems.